font size
Sign inprintPrint


Pfizer and AstraZeneca Team with Cancer Research UK to Advance Personalized Medicine

Researchers will have access to pharmas’ drug libraries, testing several drugs at same time in lung cancer trial.

A partnership among pharmaceutical powerhouses AstraZeneca and Pfizer and the not-for-profit Cancer Research UK will take a novel approach to testing targeted cancer drugs in a pioneer clinical trial for patients with advanced lung cancer. Read More
Other recent stories

Sign Up to recevie the Burrill Weekly Brief

Follow burrillreport on Twitter